The Potential of Natural Compounds Regulating Autophagy in the Treatment of Osteoporosis

References

• Song S, Guo Y, Yang Y, et al. Advances in pathogenesis and therapeutic strategies for osteoporosis. Pharmacol Ther. 2022;237:108168.
   PubMed Web of Science ®Google Scholar
• Ma Y, Ran D, Zhao H, et al. Cadmium exposure triggers osteoporosis in duck via P2X7/PI3K/AKT-mediated osteoblast and osteoclast differentiation. Sci Total Environ. 2021;750:141638. doi:10.1016/j.scitotenv.2020.141638
   PubMed Web of Science ®Google Scholar
• Lane NE. Epidemiology, etiology, and diagnosis of osteoporosis. Am J Clin Exp Obstet Gynecol. 2006;194(2 Suppl):S3–S11. doi:10.1016/j.ajog.2005.08.047
   Google Scholar
• Li J, Chen X, Lu L, et al. The relationship between bone marrow adipose tissue and bone metabolism in postmenopausal osteoporosis. Cytokine Growth Factor Rev. 2020;52:88–98. doi:10.1016/j.cytogfr.2020.02.003
   PubMed Web of Science ®Google Scholar
• Fleming A, Bourdenx M, Fujimaki M, et al. The different autophagy degradation pathways and neurodegeneration. Neuron. 2022;110(6):935–966. doi:10.1016/j.neuron.2022.01.017
   PubMed Web of Science ®Google Scholar
• Mauvezin C, Neufeld TP. Bafilomycin A1 disrupts autophagic flux by inhibiting both V-ATPase-dependent acidification and Ca-P60A/SERCA-dependent autophagosome-lysosome fusion. Autophagy. 2015;11(8):1437–1438. doi:10.1080/15548627.2015.1066957
   PubMed Web of Science ®Google Scholar
• Yuan N, Song L, Zhang S, et al. Bafilomycin A1 targets both autophagy and apoptosis pathways in pediatric B-cell acute lymphoblastic leukemia. Haematologica. 2015;100(3):345–356. doi:10.3324/haematol.2014.113324
   PubMed Web of Science ®Google Scholar
• Mizushima N, Komatsu M. Autophagy: renovation of cells and tissues. Cell. 2011;147(4):728–741. doi:10.1016/j.cell.2011.10.026
   PubMed Web of Science ®Google Scholar
• Wang L, Heckmann BL, Yang X, et al. Osteoblast autophagy in glucocorticoid-induced osteoporosis. J Cell Physiol. 2019;234(4):3207–3215. doi:10.1002/jcp.27335
   PubMed Web of Science ®Google Scholar
• Zhu C, Shen S, Zhang S, et al. Autophagy in bone remodeling: a regulator of oxidative stress. Front Endocrinol. 2022;13:898634. doi:10.3389/fendo.2022.898634
   PubMed Web of Science ®Google Scholar
• Harvey AL, Edrada-Ebel R, Quinn RJ. The re-emergence of natural products for drug discovery in the genomics era. Nat Rev Drug Discov. 2015;14(2):111–129. doi:10.1038/nrd4510
   PubMed Web of Science ®Google Scholar
• Efferth T, Oesch F. The immunosuppressive activity of artemisinin-type drugs towards inflammatory and autoimmune diseases. Med Res Rev. 2021;41(6):3023–3061. doi:10.1002/med.21842
   PubMed Web of Science ®Google Scholar
• Mizushima N, Levine B, Longo DL. Autophagy in human diseases. N Engl J Med. 2020;383(16):1564–1576. doi:10.1056/NEJMra2022774
   PubMed Web of Science ®Google Scholar
• Montaseri A, Giampietri C, Rossi M, et al. The role of autophagy in osteoclast differentiation and bone resorption function. Biomolecules. 2020;10(10):1398. doi:10.3390/biom10101398
   PubMed Web of Science ®Google Scholar
• Klionsky DJ, Petroni G, Amaravadi RK, et al. Autophagy in major human diseases. EMBO J. 2021;40(19):e108863. doi:10.15252/embj.2021108863
   PubMed Web of Science ®Google Scholar
• Guo YF, Su T, Yang M, et al. The role of autophagy in bone homeostasis. J Cell Physiol. 2021;236(6):4152–4173. doi:10.1002/jcp.30111
   PubMed Web of Science ®Google Scholar
• Levine B, Kroemer G. Biological functions of autophagy genes: a disease perspective. Cell. 2019;176(1–2):11–42. doi:10.1016/j.cell.2018.09.048
   PubMed Web of Science ®Google Scholar
• Gatica D, Lahiri V, Klionsky DJ. Cargo recognition and degradation by selective autophagy. Nat Cell Biol. 2018;20(3):233–242. doi:10.1038/s41556-018-0037-z
   PubMed Web of Science ®Google Scholar
• Lamark T, Johansen T. Mechanisms of selective autophagy. Annu Rev Cell Dev Biol. 2021;37(1):143–169. doi:10.1146/annurev-cellbio-120219-035530
   PubMedGoogle Scholar
• Licheva M, Raman B, Kraft C, et al. Phosphoregulation of the autophagy machinery by kinases and phosphatases. Autophagy. 2022;18(1):104–123. doi:10.1080/15548627.2021.1909407
   PubMed Web of Science ®Google Scholar
• Kim J, Kundu M, Viollet B, et al. AMPK and mTOR regulate autophagy through direct phosphorylation of Ulk1. Nat Cell Biol. 2011;13(2):132–141. doi:10.1038/ncb2152
   PubMed Web of Science ®Google Scholar
• Hu Y, Reggiori F. Molecular regulation of autophagosome formation. Biochem Soc Trans. 2022;50(1):55–69. doi:10.1042/BST20210819
   PubMed Web of Science ®Google Scholar
• Zhou C, Qian X, Hu M, et al. STYK1 promotes autophagy through enhancing the assembly of autophagy-specific class III phosphatidylinositol 3-kinase complex I. Autophagy. 2020;16(10):1786–1806. doi:10.1080/15548627.2019.1687212
   PubMed Web of Science ®Google Scholar
• Tremel S, Ohashi Y, Morado DR, et al. Structural basis for VPS34 kinase activation by Rab1 and Rab5 on membranes. Nat Commun. 2021;12(1):1564. doi:10.1038/s41467-021-21695-2
   PubMed Web of Science ®Google Scholar
• Wang Y, Ramos M, Jefferson M, et al. Control of infection by LC3-associated phagocytosis, CASM, and detection of raised vacuolar pH by the V-ATPase-ATG16L1 axis. Sci Adv. 2022;8(43):eabn3298. doi:10.1126/sciadv.abn3298
   PubMed Web of Science ®Google Scholar
• Glick D, Barth S, Macleod KF. Autophagy: cellular and molecular mechanisms. J Pathol. 2010;221(1):3–12. doi:10.1002/path.2697
   PubMed Web of Science ®Google Scholar
• Tian X, Teng J, Chen J. New insights regarding SNARE proteins in autophagosome-lysosome fusion. Autophagy. 2021;17(10):2680–2688. doi:10.1080/15548627.2020.1823124
   PubMed Web of Science ®Google Scholar
• Morgan NE, Cutrona MB, Simpson JC. Multitasking rab proteins in autophagy and membrane trafficking: a focus on Rab33b. Int J Mol Sci. 2019;20(16):3916. doi:10.3390/ijms20163916
   PubMed Web of Science ®Google Scholar
• Maeda K, Kobayashi Y, Koide M, et al. The regulation of bone metabolism and disorders by Wnt signaling. Int J Mol Sci. 2019;20(22):5525. doi:10.3390/ijms20225525
   PubMed Web of Science ®Google Scholar
• Zhang M, Bian YQ, Tao HM, et al. Simvastatin induces osteogenic differentiation of MSCs via Wnt/β-catenin pathway to promote fracture healing. Eur Rev Med Pharmacol Sci. 2018;22(9):2896–2905. doi:10.26355/eurrev_201805_14992
   PubMed Web of Science ®Google Scholar
• Chen X, Sun K, Zhao S, et al. Irisin promotes osteogenic differentiation of bone marrow mesenchymal stem cells by activating autophagy via the Wnt/β-catenin signal pathway. Cytokine. 2020;136:155292. doi:10.1016/j.cyto.2020.155292
   PubMed Web of Science ®Google Scholar
• Hou Z, Wang Z, Tao Y, et al. KLF2 regulates osteoblast differentiation by targeting of Runx2. Lab Invest. 2019;99(2):271–280. doi:10.1038/s41374-018-0149-x
   PubMed Web of Science ®Google Scholar
• Narayanan A, Srinaath N, Rohini M, et al. Regulation of Runx2 by MicroRNAs in osteoblast differentiation. Life Sci. 2019;232:116676. doi:10.1016/j.lfs.2019.116676
   PubMed Web of Science ®Google Scholar
• Ren C, Xu Y, Liu H, et al. Effects of runt-related transcription factor 2 (RUNX2) on the autophagy of rapamycin-treated osteoblasts. Bioengineered. 2022;13(3):5262–5276. doi:10.1080/21655979.2022.2037881
   PubMed Web of Science ®Google Scholar
• Xing L, Li Y, Li W, et al. Expression of RUNX2/LAPTM5 in the induction of MC3T3-e1 mineralization and its possible relationship with autophagy. Tissue Eng Regen Med. 2022;19(6):1223–1235. doi:10.1007/s13770-022-00477-x
   PubMed Web of Science ®Google Scholar
• Li H, Li D, Ma Z, et al. Defective autophagy in osteoblasts induces endoplasmic reticulum stress and causes remarkable bone loss. Autophagy. 2018;14(10):1726–1741. doi:10.1080/15548627.2018.1483807
   PubMed Web of Science ®Google Scholar
• Gao J, Feng Z, Wang X, et al. SIRT3/SOD2 maintains osteoblast differentiation and bone formation by regulating mitochondrial stress. Cell Death Differ. 2018;25(2):229–240. doi:10.1038/cdd.2017.144
   PubMed Web of Science ®Google Scholar
• Lee SY, An HJ, Kim JM, et al. PINK1 deficiency impairs osteoblast differentiation through aberrant mitochondrial homeostasis. Stem Cell Res Ther. 2021;12(1):589. doi:10.1186/s13287-021-02656-4
   PubMed Web of Science ®Google Scholar
• Ma S, Li S, Zhang Y, et al. BMSC-derived exosomal CircHIPK3 promotes osteogenic differentiation of MC3T3-E1 cells via mitophagy. Int J Mol Sci. 2023;24(3);1.
   Web of Science ®Google Scholar
• Maity J, Deb M, Greene C, et al. KLF2 regulates dental pulp-derived stem cell differentiation through the induction of mitophagy and altering mitochondrial metabolism. Redox Biol. 2020;36:101622. doi:10.1016/j.redox.2020.101622
   PubMed Web of Science ®Google Scholar
• Chou HC, Lin SY, Chou LY, et al. Ablation of discoidin domain receptor 1 provokes an osteopenic phenotype by regulating osteoblast/osteocyte autophagy and apoptosis. Biomedicines. 2022;10(9):2173. doi:10.3390/biomedicines10092173
   PubMed Web of Science ®Google Scholar
• Lian WS, Ko JY, Chen YS, et al. Chaperonin 60 sustains osteoblast autophagy and counteracts glucocorticoid aggravation of osteoporosis by chaperoning RPTOR. Cell Death Dis. 2018;9(10):938. doi:10.1038/s41419-018-0970-6
   PubMed Web of Science ®Google Scholar
• Su W, Lv C, Huang L, et al. Glucosamine delays the progression of osteoporosis in senile mice by promoting osteoblast autophagy. Nutr Metab. 2022;19(1):75. doi:10.1186/s12986-022-00688-y
   Google Scholar
• Zheng J, Zhu X, He Y, et al. CircCDK8 regulates osteogenic differentiation and apoptosis of PDLSCs by inducing ER stress/autophagy during hypoxia. Ann N Y Acad Sci. 2021;1485(1):56–70. doi:10.1111/nyas.14483
   PubMed Web of Science ®Google Scholar
• Wang Q, Wang H, Yan H, et al. Suppression of osteoclast multinucleation via a posttranscriptional regulation-based spatiotemporally selective delivery system. Sci Adv. 2022;8(26):eabn3333. doi:10.1126/sciadv.abn3333
   PubMed Web of Science ®Google Scholar
• Song C, Yang X, Lei Y, et al. Evaluation of efficacy on RANKL induced osteoclast from RAW264.7 cells. J Cell Physiol. 2019;234(7):11969–11975. doi:10.1002/jcp.27852
   PubMed Web of Science ®Google Scholar
• Kodama J, Kaito T. Osteoclast multinucleation: review of current literature. Int J Mol Sci. 2020;21(16). doi:10.3390/ijms21165685
   Web of Science ®Google Scholar
• Kim J-M, Lin C, Stavre Z, et al. Osteoblast-osteoclast communication and bone homeostasis. Cells. 2020;9(9):2073. doi:10.3390/cells9092073
   PubMed Web of Science ®Google Scholar
• DeSelm CJ, Miller BC, Zou W, et al. Autophagy proteins regulate the secretory component of osteoclastic bone resorption. Dev Cell. 2011;21(5):966–974. doi:10.1016/j.devcel.2011.08.016
   PubMed Web of Science ®Google Scholar
• Lee BS. Myosins in osteoclast formation and function. Biomolecules. 2018;8(4):157. doi:10.3390/biom8040157
   PubMed Web of Science ®Google Scholar
• Zhang Y, Cui Y, Wang L, et al. Autophagy promotes osteoclast podosome disassembly and cell motility athrough the interaction of kindlin3 with LC3. Cell Signalling. 2020;67:109505. doi:10.1016/j.cellsig.2019.109505
   PubMed Web of Science ®Google Scholar
• Yuan FL, Wu QY, Miao ZN, et al. Osteoclast-derived extracellular vesicles: novel regulators of osteoclastogenesis and osteoclast-osteoblasts communication in bone remodeling. Front Physiol. 2018;9:628. doi:10.3389/fphys.2018.00628
   PubMed Web of Science ®Google Scholar
• Theoleyre S, Wittrant Y, Tat SK, et al. The molecular triad OPG/RANK/RANKL: involvement in the orchestration of pathophysiological bone remodeling. Cytokine Growth Factor Rev. 2004;15(6):457–475. doi:10.1016/j.cytogfr.2004.06.004
   PubMed Web of Science ®Google Scholar
• Xiu Y, Xu H, Zhao C, et al. Chloroquine reduces osteoclastogenesis in murine osteoporosis by preventing TRAF3 degradation. J Clin Invest. 2014;124(1):297–310. doi:10.1172/JCI66947
   PubMed Web of Science ®Google Scholar
• Ke D, Yu Y, Li C, et al. Phosphorylation of BCL2 at the Ser70 site mediates RANKL-induced osteoclast precursor autophagy and osteoclastogenesis. Mol Med. 2022;28(1):22. doi:10.1186/s10020-022-00449-w
   PubMed Web of Science ®Google Scholar
• Ballard A, Zeng R, Zarei A, et al. The tethering function of mitofusin2 controls osteoclast differentiation by modulating the Ca(2+)-NFATc1 axis. J Biol Chem. 2020;295(19):6629–6640. doi:10.1074/jbc.RA119.012023
   PubMedGoogle Scholar
• Ling W, Krager K, Richardson KK, et al. Mitochondrial Sirt3 contributes to the bone loss caused by aging or estrogen deficiency. JCI Insight. 2021;6(10). doi:10.1172/jci.insight.146728
   Web of Science ®Google Scholar
• Zhu L, Wang Z, Sun X, et al. STAT3/mitophagy axis coordinates macrophage NLRP3 inflammasome activation and inflammatory bone loss. J Bone Miner Res. 2023;38(2):335–353. doi:10.1002/jbmr.4756
   PubMed Web of Science ®Google Scholar
• Huang T, Wang Y, Yu Z, et al. Effect of mitophagy in the formation of osteomorphs derived from osteoclasts. iScience. 2023;26(5):106682. doi:10.1016/j.isci.2023.106682
   PubMed Web of Science ®Google Scholar
• Fischer V, Haffner-Luntzer M. Interaction between bone and immune cells: implications for postmenopausal osteoporosis. Semin Cell Dev Biol. 2022;123:14–21. doi:10.1016/j.semcdb.2021.05.014
   PubMed Web of Science ®Google Scholar
• Nagy V, Penninger JM. The RANKL-RANK story. Gerontology. 2015;61(6):534–542. doi:10.1159/000371845
   PubMed Web of Science ®Google Scholar
• Dai W, Jiang L, Lay YA, et al. Prevention of glucocorticoid induced bone changes with beta-ecdysone. Bone. 2015;74:48–57. doi:10.1016/j.bone.2015.01.001
   PubMed Web of Science ®Google Scholar
• Shen G, Ren H, Shang Q, et al. Autophagy as a target for glucocorticoid-induced osteoporosis therapy. Cell Mol Life Sci. 2018;75(15):2683–2693. doi:10.1007/s00018-018-2776-1
   PubMed Web of Science ®Google Scholar
• Shi J, Wang L, Zhang H, et al. Glucocorticoids: dose-related effects on osteoclast formation and function via reactive oxygen species and autophagy. Bone. 2015;79:222–232. doi:10.1016/j.bone.2015.06.014
   PubMed Web of Science ®Google Scholar
• Zhu SY, Zhuang JS, Wu Q, et al. Advanced oxidation protein products induce pre-osteoblast apoptosis through a nicotinamide adenine dinucleotide phosphate oxidase-dependent, mitogen-activated protein kinases-mediated intrinsic apoptosis pathway. Aging Cell. 2018;17(4):e12764. doi:10.1111/acel.12764
   PubMed Web of Science ®Google Scholar
• Yang YH, Chen K, Li B, et al. Estradiol inhibits osteoblast apoptosis via promotion of autophagy through the ER-ERK-mTOR pathway. Apoptosis. 2013;18(11):1363–1375. doi:10.1007/s10495-013-0867-x
   PubMed Web of Science ®Google Scholar
• Sun X, Yang X, Zhao Y, et al. Effects of 17β-estradiol on mitophagy in the murine MC3T3-E1 osteoblast cell line is mediated via G protein-coupled estrogen receptor and the ERK1/2 signaling pathway. Med Sci Monit. 2018;24:903–911. doi:10.12659/MSM.908705
   PubMed Web of Science ®Google Scholar
• Gavali S, Gupta MK, Daswani B, et al. Estrogen enhances human osteoblast survival and function via promotion of autophagy. Biochim Biophys Acta. 2019;1866(9):1498–1507. doi:10.1016/j.bbamcr.2019.06.014
   PubMed Web of Science ®Google Scholar
• Cheng L, Zhu Y, Xie D, et al. Oestrogen-activated autophagy has a negative effect on the anti-osteoclastogenic function of oestrogen. Cell Prolif. 2020;53(4):e12789. doi:10.1111/cpr.12789
   PubMed Web of Science ®Google Scholar
• Ebeling PR, Nguyen HH, Aleksova J, et al. Secondary osteoporosis. Endocr Rev. 2022;43(2):240–313. doi:10.1210/endrev/bnab028
   PubMed Web of Science ®Google Scholar
• Wongdee K, Charoenphandhu N. Update on type 2 diabetes-related osteoporosis. World J Diabetes. 2015;6(5):673–678. doi:10.4239/wjd.v6.i5.673
   PubMedGoogle Scholar
• Zhang P, Liao J, Wang X, et al. High glucose promotes apoptosis and autophagy of MC3T3-E1 osteoblasts. Arch Med Sci. 2023;19(1):138–150. doi:10.5114/aoms.2020.101307
   PubMed Web of Science ®Google Scholar
• Zhao W, Zhang W, Ma H, et al. NIPA2 regulates osteoblast function by modulating mitophagy in type 2 diabetes osteoporosis. Sci Rep. 2020;10(1):3078. doi:10.1038/s41598-020-59743-4
   PubMed Web of Science ®Google Scholar
• Steinberg GR, Hardie DG. New insights into activation and function of the AMPK. Nat Rev Mol Cell Biol. 2023;24(4):255–272. doi:10.1038/s41580-022-00547-x
   PubMed Web of Science ®Google Scholar
• Zhang S, Xie Y, Yan F, et al. Negative pressure wound therapy improves bone regeneration by promoting osteogenic differentiation via the AMPK-ULK1-autophagy axis. Autophagy. 2022;18(9):2229–2245. doi:10.1080/15548627.2021.2016231
   PubMed Web of Science ®Google Scholar
• Li Y, Chen Y. AMPK and autophagy. Adv Exp Med Biol. 2019;1206:85–108.
   PubMed Web of Science ®Google Scholar
• Ge Y, Zhou M, Chen C, et al. Role of AMPK mediated pathways in autophagy and aging. Biochimie. 2022;195:100–113. doi:10.1016/j.biochi.2021.11.008
   PubMed Web of Science ®Google Scholar
• Li Y, Su J, Sun W, et al. AMP-activated protein kinase stimulates osteoblast differentiation and mineralization through autophagy induction. Int J Mol Med. 2018;41(5):2535–2544. doi:10.3892/ijmm.2018.3498
   PubMed Web of Science ®Google Scholar
• Guo X, Liang M. Metformin alleviates dexamethasone-induced apoptosis by regulating autophagy via AMPK/mTOR/p70S6K in osteoblasts. Exp Cell Res. 2022;415(1):113120. doi:10.1016/j.yexcr.2022.113120
   PubMed Web of Science ®Google Scholar
• Cai ZY, Yang B, Shi YX, et al. High glucose downregulates the effects of autophagy on osteoclastogenesis via the AMPK/mTOR/ULK1 pathway. Biochem Biophys Res Commun. 2018;503(2):428–435. doi:10.1016/j.bbrc.2018.04.052
   PubMed Web of Science ®Google Scholar
• Yao Z, Getting SJ, Locke IC. Regulation of TNF-induced osteoclast differentiation. Cells. 2021;11(1):132. doi:10.3390/cells11010132
   PubMed Web of Science ®Google Scholar
• Tong X, Gu J, Song R, et al. Osteoprotegerin inhibit osteoclast differentiation and bone resorption by enhancing autophagy via AMPK/mTOR/p70S6K signaling pathway in vitro. J Cell Biochem. 2019;120(2):1630–1642. doi:10.1002/jcb.27468
   PubMed Web of Science ®Google Scholar
• Tong X, Zhang C, Wang D, et al. Suppression of AMP-activated protein kinase reverses osteoprotegerin-induced inhibition of osteoclast differentiation by reducing autophagy. Cell Prolif. 2020;53(1):e12714. doi:10.1111/cpr.12714
   PubMed Web of Science ®Google Scholar
• Zhu K, Wu Y, He P, et al. PI3K/AKT/mTOR-targeted therapy for breast cancer. Cells. 2022;11(16):2508. doi:10.3390/cells11162508
   PubMed Web of Science ®Google Scholar
• Li H, Prever L, Hirsch E, et al. Targeting PI3K/AKT/mTOR signaling pathway in breast cancer. Cancers. 2021;13(14):1.
   Web of Science ®Google Scholar
• Leyane TS, Jere SW, Houreld NN. Cellular signalling and photobiomodulation in chronic wound repair. Int J Mol Sci. 2021;22(20):11223. doi:10.3390/ijms222011223
   PubMed Web of Science ®Google Scholar
• Zuo X, Wei X, Ju C, et al. Protective effect of photobiomodulation against hydrogen peroxide-induced oxidative damage by promoting autophagy through inhibition of PI3K/AKT/mTOR pathway in MC3T3-E1 cells. Oxid Med Cell Longev. 2022;2022:7223353. doi:10.1155/2022/7223353
   PubMed Web of Science ®Google Scholar
• Liu Y, Zhao L, He X, et al. Jintiange proteins promote osteogenesis and inhibit apoptosis of osteoblasts by enhancing autophagy via PI3K/AKT and ER stress pathways. J Ethnopharmacol. 2023;311:116399. doi:10.1016/j.jep.2023.116399
   PubMed Web of Science ®Google Scholar
• Jiang C, Wang Y, Zhang M, et al. Cholesterol inhibits autophagy in RANKL-induced osteoclast differentiation through activating the PI3K/AKT/mTOR signaling pathway. Mol Biol Rep. 2022;49(10):9217–9229. doi:10.1007/s11033-022-07747-w
   PubMed Web of Science ®Google Scholar
• Fu L, Wu W, Sun X, et al. Glucocorticoids enhanced osteoclast autophagy through the PI3K/Akt/mTOR signaling pathway. Calcif Tissue Int. 2020;107(1):60–71. doi:10.1007/s00223-020-00687-2
   PubMed Web of Science ®Google Scholar
• Zhao H, Sun Z, Ma Y, et al. Antiosteoclastic bone resorption activity of osteoprotegerin via enhanced AKT/mTOR/ULK1-mediated autophagic pathway. J Cell Physiol. 2020;235(3):3002–3012. doi:10.1002/jcp.29205
   PubMed Web of Science ®Google Scholar
• Cheng Z. The FoxO-autophagy axis in health and disease. Trends Endocrinol Metab. 2019;30(9):658–671. doi:10.1016/j.tem.2019.07.009
   PubMed Web of Science ®Google Scholar
• Ambrogini E, Almeida M, Martin-Millan M, et al. FoxO-mediated defense against oxidative stress in osteoblasts is indispensable for skeletal homeostasis in mice. Cell Metab. 2010;11(2):136–146. doi:10.1016/j.cmet.2009.12.009
   PubMed Web of Science ®Google Scholar
• Lian WS, Wu RW, Chen YS, et al. MicroRNA-29a mitigates osteoblast senescence and counteracts bone loss through oxidation resistance-1 control of FoxO3 methylation. Antioxidants. 2021;10(8):1248. doi:10.3390/antiox10081248
   Web of Science ®Google Scholar
• Jiang Y, Luo W, Wang B, et al. 1α,25-Dihydroxyvitamin D3 ameliorates diabetes-induced bone loss by attenuating FoxO1-mediated autophagy. J Biol Chem. 2021;296:100287. doi:10.1016/j.jbc.2021.100287
   PubMed Web of Science ®Google Scholar
• Gómez-Puerto MC, Verhagen LP, Braat AK, et al. Activation of autophagy by FOXO3 regulates redox homeostasis during osteogenic differentiation. Autophagy. 2016;12(10):1804–1816. doi:10.1080/15548627.2016.1203484
   PubMed Web of Science ®Google Scholar
• Yu XH, Xu XM, Zhang SX. Low-dose dexamethasone promotes osteoblast viability by activating autophagy via the SGK1/FOXO3a signaling pathway. Cell Biol Int. 2023;47(3):669–678. doi:10.1002/cbin.11971
   PubMed Web of Science ®Google Scholar
• Carafa V, Rotili D, Forgione M, et al. Sirtuin functions and modulation: from chemistry to the clinic. Clinical Epigenetics. 2016;8(1):61. doi:10.1186/s13148-016-0224-3
   PubMedGoogle Scholar
• Dai H, Sinclair DA, Ellis JL, et al. Sirtuin activators and inhibitors: promises, achievements, and challenges. Pharmacol Ther. 2018;188:140–154. doi:10.1016/j.pharmthera.2018.03.004
   PubMed Web of Science ®Google Scholar
• Kuno A, Hosoda R, Tsukamoto M, et al. SIRT1 in the cardiomyocyte counteracts doxorubicin-induced cardiotoxicity via regulating histone H2AX. Cardiovasc Res. 2023;118(17):3360–3373. doi:10.1093/cvr/cvac026
   PubMed Web of Science ®Google Scholar
• Wang Y, Mei R, Hao S, et al. Up-regulation of SIRT1 induced by 17beta-estradiol promotes autophagy and inhibits apoptosis in osteoblasts. Aging. 2021;13(20):23652–23671. doi:10.18632/aging.203639
   PubMedGoogle Scholar
• Denu RA. SIRT3 enhances mesenchymal stem cell longevity and differentiation. Oxid Med Cell Longev. 2017;2017:5841716. doi:10.1155/2017/5841716
   PubMed Web of Science ®Google Scholar
• Wang S, Yang J, Lin T, et al. Excessive production of mitochondrion‑derived reactive oxygen species induced by titanium ions leads to autophagic cell death of osteoblasts via the SIRT3/SOD2 pathway. Mol Med Rep. 2020;22(1):257–264. doi:10.3892/mmr.2020.11094
   PubMed Web of Science ®Google Scholar
• Li W, Jiang WS, Su YR, et al. PINK1/Parkin-mediated mitophagy inhibits osteoblast apoptosis induced by advanced oxidation protein products. Cell Death Dis. 2023;14(2):88. doi:10.1038/s41419-023-05595-5
   PubMed Web of Science ®Google Scholar
• Cui Y, Li B, Du J, et al. Dibutyl phthalate causes MC3T3-E1 cell damage by increasing ROS to promote the PINK1/Parkin-mediated mitophagy. Environ Toxicol. 2022;37(10):2341–2353. doi:10.1002/tox.23600
   PubMed Web of Science ®Google Scholar
• Chen L, Shi X, Weng SJ, et al. Vitamin K2 can rescue the dexamethasone-induced downregulation of osteoblast autophagy and mitophagy thereby restoring osteoblast function in vitro and in vivo. Front Pharmacol. 2020;11:1209. doi:10.3389/fphar.2020.01209
   PubMed Web of Science ®Google Scholar
• Tang H, Zhu S, Chen K, et al. IL-17A regulates autophagy and promotes osteoclast differentiation through the ERK/mTOR/Beclin1 pathway. PLoS One. 2023;18(2):e0281845. doi:10.1371/journal.pone.0281845
   PubMed Web of Science ®Google Scholar
• Chung YH, Jang Y, Choi B, et al. Beclin-1 is required for RANKL-induced osteoclast differentiation. J Cell Physiol. 2014;229(12):1963–1971. doi:10.1002/jcp.24646
   PubMed Web of Science ®Google Scholar
• Arai A, Kim S, Goldshteyn V, et al. Beclin1 modulates bone homeostasis by regulating osteoclast and chondrocyte differentiation. J Bone Miner Res. 2019;34(9):1753–1766. doi:10.1002/jbmr.3756
   PubMed Web of Science ®Google Scholar
• Tong X, Min W, Li S, et al. Beclin 1 positively regulates osteoprotegerin-induced inhibition of osteoclastogenesis by increasing autophagy in vitro. Differentiation. 2021;121:35–43. doi:10.1016/j.diff.2021.08.003
   PubMed Web of Science ®Google Scholar
• Xie X, Hu L, Mi B, et al. Metformin alleviates bone loss in ovariectomized mice through inhibition of autophagy of osteoclast precursors mediated by E2F1. Cell Commun Signal. 2022;20(1):165. doi:10.1186/s12964-022-00966-5
   PubMed Web of Science ®Google Scholar
• Qu Z, An H, Feng M, et al. Urolithin B suppresses osteoclastogenesis via inhibiting RANKL-induced signalling pathways and attenuating ROS activities. J Cell Mol Med. 2022;26(16):4428–4439. doi:10.1111/jcmm.17467
   PubMed Web of Science ®Google Scholar
• Sul OJ, Li G, Kim JE, et al. 7-ketocholesterol enhances autophagy via the ROS-TFEB signaling pathway in osteoclasts. J Nutr Biochem. 2021;96:108783. doi:10.1016/j.jnutbio.2021.108783
   PubMed Web of Science ®Google Scholar
• Park HJ, Yoon SY, Park JN, et al. Doxorubicin induces bone loss by increasing autophagy through a mitochondrial ROS/TRPML1/TFEB axis in osteoclasts. Antioxidants. 2022;11(8). doi:10.3390/antiox11081476
   Web of Science ®Google Scholar
• Walker EC, McGregor NE, Poulton IJ, et al. Oncostatin M promotes bone formation independently of resorption when signaling through leukemia inhibitory factor receptor in mice. J Clin Invest. 2010;120(2):582–592. doi:10.1172/JCI40568
   PubMed Web of Science ®Google Scholar
• Zhou J, Yang J, Dong Y, et al. Oncostatin M receptor regulates osteoblast differentiation via extracellular signal-regulated kinase/autophagy signaling. Stem Cell Res Ther. 2022;13(1):278. doi:10.1186/s13287-022-02958-1
   PubMed Web of Science ®Google Scholar
• Xue LX, Chen SF, Xue SX, et al. LncRNA TUG1 compromised neuronal mitophagy in cerebral ischemia/reperfusion injury by targeting sirtuin 1. Cell Biol Toxicol. 2022;38(6):1121–1136. doi:10.1007/s10565-022-09700-w
   PubMed Web of Science ®Google Scholar
• Su Q, Liu Y, Lv XW, et al. LncRNA TUG1 mediates ischemic myocardial injury by targeting miR-132-3p/HDAC3 axis. Am J Physiol Heart Circ Physiol. 2020;318(2):H332–H344. doi:10.1152/ajpheart.00444.2019
   PubMed Web of Science ®Google Scholar
• Lu DG, Lu MJ, Yao SH, et al. Long non-coding RNA TUG1 promotes the osteogenic differentiation of bone marrow mesenchymal stem cells by regulating the AMPK/mTOR/autophagy pathway. Biomed Res. 2021;42(6):239–246. doi:10.2220/biomedres.42.239
   PubMed Web of Science ®Google Scholar
• Jiang T, Gu H, Wei J. Echinacoside Inhibits osteoclast function by down-regulating PI3K/Akt/C-Fos to alleviate osteolysis caused by periprosthetic joint infection. Front Pharmacol. 2022;13:930053. doi:10.3389/fphar.2022.930053
   PubMed Web of Science ®Google Scholar
• Tong X, Chen M, Song R, et al. Overexpression of c-Fos reverses osteoprotegerin-mediated suppression of osteoclastogenesis by increasing the Beclin1-induced autophagy. J Cell Mol Med. 2021;25(2):937–945. doi:10.1111/jcmm.16152
   PubMed Web of Science ®Google Scholar
• Tang X, Wang P, Zhang R, et al. KLF2 regulates neutrophil activation and thrombosis in cardiac hypertrophy and heart failure progression. J Clin Invest. 2022;132(3). doi:10.1172/JCI147191
   Web of Science ®Google Scholar
• Laha D, Deb M, Das H. KLF2 (kruppel-like factor 2 [lung]) regulates osteoclastogenesis by modulating autophagy. Autophagy. 2019;15(12):2063–2075. doi:10.1080/15548627.2019.1596491
   PubMed Web of Science ®Google Scholar
• Pattingre S, Tassa A, Qu X, et al. Bcl-2 antiapoptotic proteins inhibit Beclin 1-dependent autophagy. Cell. 2005;122(6):927–939. doi:10.1016/j.cell.2005.07.002
   PubMed Web of Science ®Google Scholar
• Ke D, Ji L, Wang Y, et al. JNK1 regulates RANKL-induced osteoclastogenesis via activation of a novel Bcl-2-Beclin1-autophagy pathway. FASEB J. 2019;33(10):11082–11095. doi:10.1096/fj.201802597RR
   PubMed Web of Science ®Google Scholar
• Yang C, Tao H, Zhang H, et al. TET2 regulates osteoclastogenesis by modulating autophagy in OVX-induced bone loss. Autophagy. 2022;18(12):2817–2829. doi:10.1080/15548627.2022.2048432
   PubMed Web of Science ®Google Scholar
• Li Z, Huang Z, Zhang H, et al. P2X7 receptor induces pyroptotic inflammation and cartilage degradation in osteoarthritis via NF-κB/NLRP3 crosstalk. Oxid Med Cell Longev. 2021;2021:8868361. doi:10.1155/2021/8868361
   PubMed Web of Science ®Google Scholar
• Ma Y, Di R, Zhao H, et al. P2X7 receptor knockdown suppresses osteoclast differentiation by inhibiting autophagy and Ca 2+ /calcineurin signaling. Mol Med Rep. 2022;25(5). doi:10.3892/mmr.2022.12677
   Web of Science ®Google Scholar
• Cao B, Dai X, Wang W. Knockdown of TRPV4 suppresses osteoclast differentiation and osteoporosis by inhibiting autophagy through Ca(2+) -calcineurin-NFATc1 pathway. J Cell Physiol. 2019;234(5):6831–6841. doi:10.1002/jcp.27432
   PubMed Web of Science ®Google Scholar
• Yang L, Liu S, Mu S, et al. Paeoniflorin attenuates dexamethasone-induced apoptosis of osteoblast cells and promotes bone formation via regulating AKT/mTOR/autophagy signaling pathway. Evid Based Complement Alternat Med. 2021;2021:6623464. doi:10.1155/2021/6623464
   PubMed Web of Science ®Google Scholar
• Zhao B, Peng Q, Wang D, et al. Leonurine protects bone mesenchymal stem cells from oxidative stress by activating mitophagy through PI3K/Akt/mTOR pathway. Cells. 2022;11(11):1724. doi:10.3390/cells11111724
   PubMed Web of Science ®Google Scholar
• Zhao B, Peng Q, Poon EHL, et al. Leonurine promotes the osteoblast differentiation of rat BMSCs by activation of autophagy via the PI3K/Akt/mTOR pathway. Front Bioeng Biotechnol. 2021;9:615191. doi:10.3389/fbioe.2021.615191
   PubMed Web of Science ®Google Scholar
• Malaguarnera L. Influence of resveratrol on the immune response. Nutrients. 2019;11(5). doi:10.3390/nu11050946
   Web of Science ®Google Scholar
• Breuss JM, Atanasov AG, Uhrin P. Resveratrol and its effects on the vascular system. Int J Mol Sci. 2019;20(7):1523. doi:10.3390/ijms20071523
   PubMed Web of Science ®Google Scholar
• Yang X, Jiang T, Wang Y, et al. The role and mechanism of SIRT1 in resveratrol-regulated osteoblast autophagy in osteoporosis rats. Sci Rep. 2019;9(1):18424. doi:10.1038/s41598-019-44766-3
   PubMed Web of Science ®Google Scholar
• Gao S, Feng Q. The beneficial effects of geniposide on glucose and lipid metabolism: a review. Drug Des Devel Ther. 2022;16:3365–3383. doi:10.2147/DDDT.S378976
   PubMed Web of Science ®Google Scholar
• Huang J, Ye Y, Xiao Y, et al. Geniposide ameliorates glucocorticoid-induced osteoblast apoptosis by activating autophagy. Biomed Pharmacother. 2022;155:113829. doi:10.1016/j.biopha.2022.113829
   PubMed Web of Science ®Google Scholar
• Tang YH, Yue ZS, Li GS, et al. Effect of β‑ecdysterone on glucocorticoid‑induced apoptosis and autophagy in osteoblasts. Mol Med Rep. 2018;17(1):158–164. doi:10.3892/mmr.2017.7840
   PubMed Web of Science ®Google Scholar
• Tang Y, Mo Y, Xin D, et al. Regulation of osteoblast autophagy based on PI3K/AKT/mTOR signaling pathway study on the effect of β-ecdysterone on fracture healing. J Orthop Surg Res. 2021;16(1):719. doi:10.1186/s13018-021-02862-z
   PubMed Web of Science ®Google Scholar
• Zeng C, Wang S, Chen F, et al. Alpinetin alleviates osteoporosis by promoting osteogenic differentiation in BMSCs by triggering autophagy via PKA/mTOR/ULK1 signaling. Phytother Res. 2023;37(1):252–270. doi:10.1002/ptr.7610
   PubMed Web of Science ®Google Scholar
• Dong GM, Yu H, Pan LB, et al. Biotransformation of timosaponin BII into seven characteristic metabolites by the gut microbiota. Molecules. 2021;26(13):3861. doi:10.3390/molecules26133861
   PubMed Web of Science ®Google Scholar
• Wang N, Xu P, Wu R, et al. Timosaponin BII improved osteoporosis caused by hyperglycemia through promoting autophagy of osteoblasts via suppressing the mTOR/NFκB signaling pathway. Free Radic Biol Med. 2021;171:112–123. doi:10.1016/j.freeradbiomed.2021.05.014
   PubMed Web of Science ®Google Scholar
• Rashid M, Singh SK, Malik MY, et al. Development and validation of UPLC-MS/MS assay for quantification of cladrin: absolute bioavailability and dose proportionality study in rats. J Pharm Biomed Anal. 2018;152:289–297. doi:10.1016/j.jpba.2018.01.044
   PubMed Web of Science ®Google Scholar
• Rai R, Singh KB, Khanka S, et al. Cladrin alleviates dexamethasone-induced apoptosis of osteoblasts and promotes bone formation through autophagy induction via AMPK/mTOR signaling. Free Radic Biol Med. 2022;190:339–350. doi:10.1016/j.freeradbiomed.2022.08.028
   PubMed Web of Science ®Google Scholar
• Yue C, Jin H, Zhang X, et al. Aucubin prevents steroid-induced osteoblast apoptosis by enhancing autophagy via AMPK activation. J Cell Mol Med. 2021;25(21):10175–10184. doi:10.1111/jcmm.16954
   PubMed Web of Science ®Google Scholar
• Mizunoe Y, Kobayashi M, Sudo Y, et al. Trehalose protects against oxidative stress by regulating the Keap1-Nrf2 and autophagy pathways. Redox Biol. 2018;15:115–124. doi:10.1016/j.redox.2017.09.007
   PubMed Web of Science ®Google Scholar
• Pupyshev AB, Klyushnik TP, Akopyan AA, et al. Disaccharide trehalose in experimental therapies for neurodegenerative disorders: molecular targets and translational potential. Pharmacol Res. 2022;183:106373. doi:10.1016/j.phrs.2022.106373
   PubMed Web of Science ®Google Scholar
• Zhu L, Yuan Y, Yuan L, et al. Activation of TFEB-mediated autophagy by trehalose attenuates mitochondrial dysfunction in cisplatin-induced acute kidney injury. Theranostics. 2020;10(13):5829–5844. doi:10.7150/thno.44051
   PubMed Web of Science ®Google Scholar
• Cao L, Zhou S, Qiu X, et al. Trehalose improves palmitic acid-induced apoptosis of osteoblasts by regulating SIRT3 -medicated autophagy via the AMPK/mTOR / ULK1 pathway. FASEB J. 2022;36(9):e22491. doi:10.1096/fj.202200608RR
   PubMed Web of Science ®Google Scholar
• Wang L, Zhang HY, Gao B, et al. Tetramethylpyrazine protects against glucocorticoid-induced apoptosis by promoting autophagy in mesenchymal stem cells and improves bone mass in glucocorticoid-induced osteoporosis rats. Stem Cells Dev. 2017;26(6):419–430. doi:10.1089/scd.2016.0233
   PubMed Web of Science ®Google Scholar
• Zhang B, Yang LL, Ding SQ, et al. Anti-osteoporotic activity of an edible traditional Chinese medicine cistanche deserticola on bone metabolism of ovariectomized rats through RANKL/RANK/TRAF6-mediated signaling pathways. Front Pharmacol. 2019;10:1412. doi:10.3389/fphar.2019.01412
   PubMed Web of Science ®Google Scholar
• Xu X, Zhang Z, Wang W, et al. Therapeutic effect of cistanoside A on bone metabolism of ovariectomized mice. Molecules. 2017;22(2):1.
   Web of Science ®Google Scholar
• Chen T, Gao F, Luo D, et al. Cistanoside A promotes osteogenesis of primary osteoblasts by alleviating apoptosis and activating autophagy through involvement of the Wnt/β-catenin signal pathway. Ann Transl Med. 2022;10(2):64. doi:10.21037/atm-21-6742
   PubMed Web of Science ®Google Scholar
• Kim CJ, Shin SH, Kim BJ, et al. The effects of Kaempferol-inhibited autophagy on osteoclast formation. Int J Mol Sci. 2018;19(1):1.
   Web of Science ®Google Scholar
• Chen Z, Xue J, Shen T, et al. Curcumin alleviates glucocorticoid-induced osteoporosis through the regulation of the Wnt signaling pathway. Int J Mol Med. 2016;37(2):329–338. doi:10.3892/ijmm.2015.2432
   PubMed Web of Science ®Google Scholar
• Ke D, Wang Y, Yu Y, et al. Curcumin-activated autophagy plays a negative role in its anti-osteoclastogenic effect. Mol Cell Endocrinol. 2020;500:110637. doi:10.1016/j.mce.2019.110637
   PubMed Web of Science ®Google Scholar
• Nahak P, Gajbhiye RL, Karmakar G, et al. Orcinol glucoside loaded polymer - lipid hybrid nanostructured lipid carriers: potential cytotoxic agents against gastric, colon and hepatoma carcinoma cell lines. Pharm Res. 2018;35(10):198. doi:10.1007/s11095-018-2469-3
   PubMed Web of Science ®Google Scholar
• Gong W, Liu M, Zhang Q, et al. Orcinol glucoside improves senile osteoporosis through attenuating oxidative stress and autophagy of osteoclast via activating Nrf2/Keap1 and mTOR signaling pathway. Oxid Med Cell Longev. 2022;2022:5410377. doi:10.1155/2022/5410377
   PubMed Web of Science ®Google Scholar
• Yuan Q, Zhang X, Wei W, et al. Lycorine improves peripheral nerve function by promoting Schwann cell autophagy via AMPK pathway activation and MMP9 downregulation in diabetic peripheral neuropathy. Pharmacol Res. 2022;175:105985. doi:10.1016/j.phrs.2021.105985
   PubMed Web of Science ®Google Scholar
• Park HJ, Gholam-Zadeh M, Suh JH, et al. Lycorine attenuates autophagy in osteoclasts via an axis of mROS/TRPML1/TFEB to reduce LPS-induced bone loss. Oxid Med Cell Longev. 2019;2019:8982147. doi:10.1155/2019/8982147
   PubMed Web of Science ®Google Scholar
• Xu J, Xu Z, Zheng W. A review of the antiviral role of green tea catechins. Molecules. 2017;22(8). doi:10.3390/molecules22081337
   Web of Science ®Google Scholar
• Sarkar J, Das M, Howlader MSI, et al. Epigallocatechin-3-gallate inhibits osteoclastic differentiation by modulating mitophagy and mitochondrial functions. Cell Death Dis. 2022;13(10):908. doi:10.1038/s41419-022-05343-1
   PubMed Web of Science ®Google Scholar